NCT01215474已完成不适用
Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC
Provitro GmbH1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2010年10月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 500
- 试验地点
- 1
研究概览
简要总结
While current mutational analyses comprise exons 19 and 21 in which the majority of EGFR-mutations occur, this study aims at investigating the relevance of exon 18 and 20 mutations. Therefore, the investigators analyse 500 routine tumor samples with respect to the above mentioned exons and correlate the results to the clinical outcome. This approach will enable us to potentially identify patients that might in the future benefit from targeted therapy (EGFR-inhibition).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •NSCLC Stadium III-IV
排除标准
- •no NSCLC or different stadium
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation StudyEGFR Mutation Positive Non Small Cell Lung CancerNCT01838577European Organisation for Research and Treatment of Cancer - EORTC2,000
已完成
不适用
NGS Genome Analysis in Personalisation of Lung Cancer TreatmentLung CancerNCT02281214Centre Georges Francois Leclerc165
已完成
不适用
Mutation analyses of plasma and tumor DNA in EGFR mutation-positive advanced non-small-cell lung cancer.non-small-cell lung cancerJPRN-UMIN000016879Clinical Research Support Center Kyushu100
已完成
不适用
EGFR Mutations on ctDNA in Patients With Advanced NSCLCNon-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer MetastaticNCT02623257First People's Hospital of Hangzhou1,055
已完成
不适用
Analysis of EGFR mutation using highly sensitive droplet digital PCR in non-small cell lung cancer patients with EGFR mutations.lung cancerJPRN-UMIN000038648agasaki University Hospital5